FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan
      ·

      abt

      ·

      Evercore ISI Lowers Price Target for Abbott Laboratories, Maintains Positive Outlook

      Abbott Laboratories, a prominent player in the healthcare sector, has been recognized as one of the top 15 consistent dividend stocks to consider for investment. On April 6, Evercore ISI analyst Vijay Kumar adjusted the price target for Abbott's shares, reducing it from $138 to $134 while retaining an Outperform rating.

      This revision is part of Evercore ISI's preview for the first quarter, reflecting the firm's ongoing assessment of Abbott's market performance. Despite the lowered price target, the positive rating indicates confidence in the company's long-term prospects.

      © 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

      Source: KLEA News

      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud